NFKB1 and hepatocellular carcinoma: Our results have demonstrated that the HBx-induced drug resistance of HCC is associated with the activation of NF-κB canonical pathways, which was based on inducible IκBα degradation, allowing NF-κB dimers (mainly p65/p50 dimers) to accumulate in the nucleus and activate transcription.